Induction of apoptosis in hormone-resistant human prostate cancer PC3 cells by inactivated Sendai virus

Biomedical and Environmental Sciences

Volumn 27, Issue 7, 2014, Pages 506-514

  Gao, Hui ^a   Gong, Xiao Cheng ^a   Chen, Ze Dong ^a   Xu, Xiao Shuang ^a   Zhang, Quan ^a   Xu, Xiang Ming ^a,b  

^a YANGZHOU UNIVERSITY   (China)

^b SUZHOU POLYTECHNIC INSTITUTE OF AGRICULTURE   (China)

Author keywords

Inactivated Sendai virus (HVJ E) Apoptosis Caspase Mitogen activated protein kinase (MAPK)

Indexed keywords

CANCER VACCINE; CASPASE; INACTIVATED VACCINE;

ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOLOGY; INACTIVATED SENDAI VIRUS (HVJ-E); MALE; MITOGEN-ACTIVATED PROTEIN KINASE (MAPK); MOUSE; ONCOLYTIC VIROTHERAPY; PHYSIOLOGY; PROSTATE TUMOR; SENDAI VIRUS; TUMOR CELL LINE;

APOPTOSIS; CASPASE; INACTIVATED SENDAI VIRUS (HVJ-E); MITOGEN-ACTIVATED PROTEIN KINASE (MAPK);

ANIMALS; APOPTOSIS; CANCER VACCINES; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, INBRED BALB C; ONCOLYTIC VIROTHERAPY; PROSTATIC NEOPLASMS; SENDAI VIRUS; VACCINES, INACTIVATED;

EID: 84906568205     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: 10.3967/bes2014.082     Document Type: Article

References (28)

1. A Russo, CL Espinoza, S Caggia et al. A new jasmonic acid stereoisomeric derivative induces apoptosis via reactive oxygen species in human prostate cancer cells Cancer letters 326 2012 199 205
2. ES Antonarakis, MA Carducci, MA Eisenberger Novel targeted therapeutics for metastatic castration-resistant prostate cancer Cancer letters 291 2010 1 13
3. T Matsushima-Miyagi, K Hatano, M Nomura et al. TRAIL and Noxa Are Selectively Upregulated in Prostate Cancer Cells Downstream of the RIG-I/MAVS Signaling Pathway by Nonreplicating Sendai Virus Particles Clin Cancer Res 18 2012 6271 6283
4. TC Liu, D Kirn Gene therapy progress and prospects cancer: oncolytic viruses Gene therapy 15 2008 877 884
5. AI Freeman, Z Zakay-Rones, JM Gomori et al. Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme Mol Ther 13 2006 221 228
6. S Meng, Z Zhou, F Chen et al. Newcastle disease virus induces apoptosis in cisplatin-resistant human lung adenocarcinoma A549 cells in vitro and in vivo Cancer letters 317 2012 56 64
7. JG Sinkovics, JC Horvath Newcastle disease virus (NDV): brief history of its oncolytic strains J Clin Virol 16 2000 1 15
8. LK Csatary, RW Moss, J Beuth et al. Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68/H) Anticancer research 19 1999 635 638
9. P Msaouel, ID Iankov, C Allen et al. Engineered measles virus as a novel oncolytic therapy against prostate cancer The Prostate 69 2009 82 91
10. Y Kaneda Virosome: A novel vector to enable multi-modal strategies for cancer therapy Advanced drug delivery reviews 64 2012 730 738
11. M Kurooka, Y Kaneda Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells Cancer research 67 2007 227 236
12. A Fujihara, M Kurooka, T Miki et al. Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation Cancer Immunol Immunother 57 2008 73 84
13. Y Kaneda A non-replicating oncolytic vector as a novel therapeutic tool against cancer BMB reports 43 2010 773 780
14. Y Kawaguchi, Y Miyamoto, T Inoue et al. Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle International journal of cancer 124 2009 2478 2487
15. Q Zhang, Z Wang, Y Yuan et al. Immunoadjuvant effects of hemagglutinating virus of Japan envelope (HVJ-E) on the inactivated H9 subtype avian influenza virus vaccine Veterinary immunology and immunopathology 141 2011 116 123
16. B Bellei, E Flori, E Izzo et al. GSK3beta inhibition promotes melanogenesis in mouse B16 melanoma cells and normal human melanocytes Cellular signalling 20 2008 1750 1761
17. TB Karasic, TK Hei, VN Ivanov Disruption of IGF-1R signaling increases TRAIL-induced apoptosis: A new potential therapy for the treatment of melanoma Experimental cell research 1994-2007 316
18. F Liu, J Gu Retinoic acid inducible gene-I, more than a virus sensor Protein & cell 2 2011 351 357
19. H Kato, O Takeuchi, S Sato et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses Nature 441 2006 101 105
20. SH Juang, SJ Wei, YM Hung et al. IFN-beta induces caspase-mediated apoptosis by disrupting mitochondria in human advanced stage colon cancer cell lines J Interferon Cytokine Res 24 2004 231 243
21. M Chawla-Sarkar, DW Leaman, EC Borden Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines Clin Cancer Res 7 2001 1821 1831
22. L Li, J Zhang, B Jin et al. Nitric oxide upregulation of caspase-8 mRNA expression in lung endothelial cells: role of JAK2/STAT-1 signaling Molecular and cellular biochemistry 305 2007 71 77
23. J Bian, K Wang, X Kong et al. Caspase- and p38-MAPK-dependent induction of apoptosis in A549 lung cancer cells by Newcastle disease virus Archives of virology 156 2011 1335 1344
24. CJ Breitbach, SH Thorne, JC Bell et al. Targeted and armed oncolytic poxviruses for cancer: The lead example of JX-594 Current pharmaceutical biotechnology 13 2012 1768 1772
25. B Yaacov, E Eliahoo, I Lazar et al. Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors Cancer gene therapy 15 2008 795 807
26. L Heinzerling, V Kunzi, PA Oberholzer et al. Oncolytic measles virus in cutaneous T-cell lymphomas mounts antitumor immune responses in vivo and targets interferon-resistant tumor cells Blood 106 2005 2287 2294
27. M Matsuda, K Nimura, T Shimbo et al. Immunogene therapy using immunomodulating HVJ-E vector augments anti-tumor effects in murine malignant glioma Journal of neuro-oncology 103 2011 19 31
28. Q Zhang, WF Yuan, GQ Zhai et al. Inactivated Sendai Virus Suppresses Murine Melanoma Growth by Inducing Host Immune Responses and Down-regulating β-catenin Expression Biomed Environ Sci 25 2012 509 516